Sentences with phrase «other shareholder litigation»

He has led a wide variety of internal investigations centered in the United States and China, and has represented executives, directors and auditors in internal investigations, SEC investigations and enforcement actions, and in securities class actions and other shareholder litigation.

Not exact matches

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

Actual results may vary materially from those expressed or implied by forward - looking statements based on a number of factors, including, without limitation: (1) risks related to the consummation of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated time period, or at all, (b) the parties may fail to obtain shareholder approval of the Merger Agreement, (c) the parties may fail to secure the termination or expiration of any waiting period applicable under the HSR Act, (d) other conditions to the consummation of the Merger under the Merger Agreement may not be satisfied, (e) all or part of Arby's financing may not become available, and (f) the significant limitations on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the effects that any termination of the Merger Agreement may have on BWW or its business, including the risks that (a) BWW's stock price may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW to pay Arby's a termination fee of $ 74 million, or (c) the circumstances of the termination, including the possible imposition of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives to the Merger; (3) the effects that the announcement or pendency of the Merger may have on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from other important matters; (4) the effect of limitations that the Merger Agreement places on BWW's ability to operate its business, return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings, including any such proceedings related to the Merger and instituted against BWW and others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7) other economic, business, competitive, legal, regulatory, and / or tax factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with the SEC.

Each share class represents an interest in the same assets of the Funds, has the same rights and is identical in all material respects except that (i) each class of shares may be subject to different (or no) sales loads, (ii) each class of shares may bear different (or no) distribution fees; (iii) each class of shares may have different shareholder features, such as minimum investment amounts; (iv) certain other class - specific expenses will be borne solely by the class to which such expenses are attributable, including transfer agent fees attributable to a specific class of shares, printing and postage expenses related to preparing and distributing materials to current shareholders of a specific class, registration fees paid by a specific class of shares, the expenses of administrative personnel and services required to support the shareholders of a specific class, litigation or other legal expenses relating to a class of shares, Trustees» fees or expenses paid as a result of issues relating to a specific class of shares and accounting fees and expenses relating to a specific class of shares and (v) each class has exclusive voting rights with respect to matters relating to its own distribution arrangements.

The investigation and conclusions of the Special Committee may result in claims and proceedings relating to such matters, including previously disclosed shareholder and derivative litigation and actions by the Securities and Exchange Commission and / or other governmental agencies and negative tax or other implications for the Company resulting from any accounting adjustments or other factors.

He is regularly instructed on disputes concerning civil fraud and asset tracing, banking and other financial litigation, and company law disputes of one sort of another (including shareholder disputes or claims against directors).

Gary has litigated cases involving claims arising from business sales and acquisitions, securities claims, employment disputes, shareholder disputes, environmental matters and other business litigation.

Raman practices in the areas of civil litigation including estate, commercial, real estate, debtor & creditor matters, business and shareholder disputes including oppression remedies, corporate governance disputes in not - for - profit corporations, and other areas in litigation.

OTHER PUBLIC RECORDS SEARCHES: In addition to the real and personal property searches described above, the target should also be searched to determine if there are any past or present bankruptcy filings, if it has provided any security under the Bank Act of Canada, if the target or its shareholders are involved in any past or present litigation and if there are any violations or unpaid remittances with the Canada Revenue Agency, Employment Standards Branch, Workplace Safety and Health, Workers Compensation Board or other governmental agenOTHER PUBLIC RECORDS SEARCHES: In addition to the real and personal property searches described above, the target should also be searched to determine if there are any past or present bankruptcy filings, if it has provided any security under the Bank Act of Canada, if the target or its shareholders are involved in any past or present litigation and if there are any violations or unpaid remittances with the Canada Revenue Agency, Employment Standards Branch, Workplace Safety and Health, Workers Compensation Board or other governmental agenother governmental agencies.

Our expertise includes advising officers, boards of directors, shareholders, and special litigation committees on a wide range of business disputes, including fiduciary duties, employment issues with minority and majority shareholders, executive compensation, corporate freeze - outs, direct and derivative claims by shareholders, internal investigations and other aspects of corporate governance.

Defended derivative litigation suit in which a minority shareholder sued the company and other board members for self - dealing and corporate waste.

Among others, Mr. Ferdinand's experience includes, appellate litigation; bankruptcy adversary proceedings; bid protests, debarments, and appeals; breach of contract and Uniform Commercial Code claims; broker disputes; commercial landlord - tenant actions, including commercial evictions; condominium association litigation; consumer fraud and deceptive trade practices act claims; corporate governance; directors» and officers» claims; ethics and professional liability; health law; injunctions; insurance issues; lien claims, including commercial and residential construction liens; planning board actions; post-judgment collection; restrictive covenants; shareholder and partnership disputes; and shareholder derivative claims.

Representation of minority shareholders in home healthcare franchising companies in various state court litigation involving breach of fiduciary duty, breach of a shareholders» agreement, fraud and other tort claims, including successfully prosecuting charges for violation of court orders freezing millions of corporate funds, resulting in a civil contempt judgment that included a jail sentence.

The year 2017 saw two notable decisions in the area of shareholder derivative and class actions, one granting a corporation's motion to dismiss a derivative suit based on the results of a special litigation committee investigation, the other upholding the denial of class certification on the grounds that the proposed class representative could not adequately represent the class.

We regularly handle regulatory matters, provide advice on the introduction of new products or services to the financial market, negotiate mergers and acquisitions, investment and securitization transactions, and represent clients in collection, shareholder, and other litigation, as well as in administrative enforcement matters.

Defense of leading U.S. pharmaceutical and biologic manufacturers in national and international product liability and commercial litigation involving prescription biologics, nonsteroidal pain medications, diet drugs, statins and other medications, including class actions, multi-district litigations, Congressional investigations, criminal proceedings, and shareholder derivative litigation

Judge Simon has assisted in the resolution of complex commercial cases, injunctive relief matters, corporate and shareholder proceedings, employment disputes, land use litigation, prerogative writ actions, contested estates and guardianships, election disputes, and other significant litigated matters.

Weber brings a broad securities litigation practice, representing clients in a diverse array of matters including securities class actions, shareholder derivative actions, proceedings initiated by the Securities and Exchange Commission and other regulatory authorities, internal corporate investigations, arbitrations and other complex commercial litigation.

Lindsay Kenney acts on behalf of local and international clients in relation to business disputes, fraud claims, partnership and shareholder disputes, in bankruptcy proceedings, construction claims, employment litigation, intellectual property litigation, defamation claims, professional liability issues, complex litigation matters and other administrative and regulatory issues, including appeals.

In civil litigation matters, Mr. Cloherty regularly represents companies, executives and professionals in complex business disputes, including breaches of contracts, breaches of fiduciary duties, shareholder disputes, trade secrets theft, non-competition agreements, wage and hour disputes, and other employment issues.

For a Bradenton, Lakewood Ranch and Sarasota attorney for complex litigation, shareholder disputes and other concerns, contact us today.

While Nick's general litigation practice focuses on real estate and construction law and personal injury and product liability law, he also handles a number of other complex commercial disputes, including misappropriation of trade secrets and shareholder derivative actions.

Additionally, recognizing that a cyber - or privacy - related development can expand to encompass a number of other significant legal issues, our group works hand - in - glove with attorneys in our White Collar Defense, Regulatory and Investigations, Securities Litigation, Complex Commercial Litigation, Business Finance & Restructuring and Employment Litigation practices, among others, to address subsequent risks such as government or regulatory inquiries, shareholder, consumer, or employee class action litigation, trade secrets theft, funding or financial issues, and disputes with vendors, service providers and other thirLitigation, Complex Commercial Litigation, Business Finance & Restructuring and Employment Litigation practices, among others, to address subsequent risks such as government or regulatory inquiries, shareholder, consumer, or employee class action litigation, trade secrets theft, funding or financial issues, and disputes with vendors, service providers and other thirLitigation, Business Finance & Restructuring and Employment Litigation practices, among others, to address subsequent risks such as government or regulatory inquiries, shareholder, consumer, or employee class action litigation, trade secrets theft, funding or financial issues, and disputes with vendors, service providers and other thirLitigation practices, among others, to address subsequent risks such as government or regulatory inquiries, shareholder, consumer, or employee class action litigation, trade secrets theft, funding or financial issues, and disputes with vendors, service providers and other thirlitigation, trade secrets theft, funding or financial issues, and disputes with vendors, service providers and other third parties.

Abbie specialises in professional negligence claims (mainly against solicitors, accountancy practitioners and other finance professionals), general commercial litigation matters (including warranty, contractual and director / shareholder disputes) and insolvency matters.

Mr Holden advises on a broad range of litigation matters including complex trust, contractual and commercial disputes, shareholder, investor and funds actions, cross-border and international litigation, injunctions and other applications.

His work includes medical device product liability work, produce liability work in other spheres, public procurement disputes, professional negligence, construction disputes, technology development disputes, commercial contract disputes, shareholder and partnership disputes, financial and banking litigation, professional regulation and disciplinary, fraud and judicial review.

Mr. Cotten practices law as a shareholder in Baron & Budd's Mesothelioma Litigation Group, representing individuals with mesothelioma and other asbestos - related diseases.

Drawing on his extensive international experience, Richard advises on a broad range of litigation matters, including complex trust, contractual and commercial disputes, shareholder, investor and funds actions, cross-border and international litigation, injunctions and other applications.

In addition, Travis represents plaintiffs and defendants in complex business matters with a particular emphasis on technology, marketing and media disputes, copyrights and trademarks, along with fiduciary litigation, partnership and shareholder disputes and other «business divorce» cases.

Clients with major transactions routinely face shareholder and other litigation seeking to block or enforce a deal.

Amy's other recent and ongoing work includes Commercial Court proceedings and an LCIA action in a multi-jurisdictional shareholder dispute, a substantial contractual claim in the TCC arising from a complex IT implementation, litigation between the former CEO of Group Lotus and his former employer and its Malaysian shareholders, unfair competition litigation brought by Swiss IDB ContiCap, an LCIA arbitration in the media sector, and conspiracy claims in team poaching litigation between insurance brokers Willis and JLT, and between IDBs Tullett Prebon and BGC Brokers.

And in other news, «Lerach's Guilty Plea Gives Coke New Defense in Securities Fraud Case; Claim about lawyer's tactics stems from shareholder litigation alleging Coke artificially inflated revenues and stock prices.»